全文获取类型
收费全文 | 239663篇 |
免费 | 13763篇 |
国内免费 | 579篇 |
专业分类
耳鼻咽喉 | 2878篇 |
儿科学 | 7709篇 |
妇产科学 | 5275篇 |
基础医学 | 33028篇 |
口腔科学 | 8302篇 |
临床医学 | 21400篇 |
内科学 | 52639篇 |
皮肤病学 | 5654篇 |
神经病学 | 20737篇 |
特种医学 | 6880篇 |
外国民族医学 | 55篇 |
外科学 | 28369篇 |
综合类 | 1860篇 |
现状与发展 | 1篇 |
一般理论 | 122篇 |
预防医学 | 24642篇 |
眼科学 | 4190篇 |
药学 | 14671篇 |
中国医学 | 814篇 |
肿瘤学 | 14779篇 |
出版年
2023年 | 1248篇 |
2022年 | 2390篇 |
2021年 | 4779篇 |
2020年 | 3135篇 |
2019年 | 4701篇 |
2018年 | 6626篇 |
2017年 | 4887篇 |
2016年 | 4619篇 |
2015年 | 5530篇 |
2014年 | 7319篇 |
2013年 | 9860篇 |
2012年 | 15473篇 |
2011年 | 16033篇 |
2010年 | 8164篇 |
2009年 | 7145篇 |
2008年 | 13125篇 |
2007年 | 13812篇 |
2006年 | 13031篇 |
2005年 | 13231篇 |
2004年 | 12611篇 |
2003年 | 11595篇 |
2002年 | 9511篇 |
2001年 | 6149篇 |
2000年 | 6146篇 |
1999年 | 5471篇 |
1998年 | 2120篇 |
1997年 | 1760篇 |
1996年 | 1715篇 |
1995年 | 1466篇 |
1994年 | 1431篇 |
1993年 | 1310篇 |
1992年 | 3311篇 |
1991年 | 3136篇 |
1990年 | 2895篇 |
1989年 | 2866篇 |
1988年 | 2570篇 |
1987年 | 2419篇 |
1986年 | 2231篇 |
1985年 | 2159篇 |
1984年 | 1616篇 |
1983年 | 1333篇 |
1982年 | 857篇 |
1981年 | 742篇 |
1980年 | 725篇 |
1979年 | 1155篇 |
1978年 | 772篇 |
1977年 | 643篇 |
1975年 | 670篇 |
1974年 | 723篇 |
1973年 | 692篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies
Bayard L. Powell Hyman B. Muss Robert L. Capizzi Mary E. Caponera Douglas R. White Patricia J. Zekan James N. Atkins Don V. Jackson Jr. Frederick Richards II John B. Craig Julia M. Cruz Charles L. Spurr 《Cancer chemotherapy and pharmacology》1987,19(3):250-252
Summary Cytosine arabinsodie (ara-C) and etoposide (VP-16) display synergy in the laboratory. Twenty-six patients participated in a phase I study of high-dose ara-C in combination with VP-16. The dose of VP-16 was held constant at 50 mg/m2 as an intermittent infusion over 33 h; escalating doses of ara-C were given as infusions during hours 9–12 and 21–24. Myelosuppression was the dose-limiting toxicity and occurred with doses considerably less than those expected from studies of the two drugs as single agents. The suggested initial doses for phase II trials with this schedule are 750 mg/m2×2 doses of ara-C and 50 mg/m2 of VP-16. Nonhematologic toxicity was minimal; therefore, further dose escalation is feasible in patients in whom myelosuppression is acceptable.Supported in part by grants from the National Cancer Institute (CA-12197 and CA-09422) and the American Cancer Society CF-85-182 相似文献
32.
33.
Alcoholic liver disease: an IgA-associated disorder 总被引:1,自引:0,他引:1
34.
35.
36.
Joseph M Dhahbi Shelley X Cao Patricia L Mote Brian C Rowley John E Wingo Stephen R Spindler 《The Journal of nutrition》2002,132(1):31-37
Molecular chaperones assist in the biosynthesis and processing of proteins. Most chaperones are induced by physiological stresses. We have shown that dietary energy restriction decreases the mRNA and protein levels of many endoplasmic reticulum chaperones in the livers of mice. Here, we have investigated the response of chaperone mRNA to feeding. Control and 50% energy-restricted C3B10RF1 mice were deprived of food for 24 h, fed, and killed 0, 1.5, 5 or 12 h after feeding. Chaperone mRNAs were strongly induced as early as 1.5 h after feeding in control and energy-restricted mice. The integrated levels of these mRNA over 24 h were significantly lower in energy-restricted mice. The mRNA response to energy intake was mirrored over the course of days in the level of chaperone protein. A similar but smaller response to feeding was found in kidney and muscle. Puromycin and cycloheximide failed to inhibit the feeding response, suggesting that feeding releases chaperone expression from an unstable inhibitor. Studies with dibutyryl-cAMP- and glucagon-supplemented, normal and streptozotocin-diabetic mice suggest that glucagon and insulin may be mediators of the feeding response. Adrenalectomy enhanced the feeding induction, but dexamethasone administration had no effect. Thus, postprandial changes in insulin and glucagon may link chaperone gene expression to feeding, possibly in several tissues including liver. 相似文献
37.
E Maquarre C Artus Z Gadhoum C Jasmin F Smadja-Joffe J Robert-Lézénès 《Leukemia》2005,19(12):2296-2303
We have recently reported that ligation of the CD44 cell surface antigen with A3D8 monoclonal antibody (mAb) triggers incomplete differentiation and apoptosis of the acute promyelocytic leukemia (APL)-derived NB4 cells. The present study characterizes the mechanisms underlying the apoptotic effect of A3D8 in NB4 cells. We show that A3D8 induces activation of both initiator caspase-8 and -9 and effector caspase-3 and -7 but only inhibition of caspase-3/7 and caspase-8 reduces A3D8-induced apoptosis. Moreover, A3D8 induces mitochondrial alterations (decrease in mitochondrial membrane potential DeltaPsi m and cytochrome c release), which are reduced by caspase-8 inhibitor, suggesting that caspase-8 is primarily involved in A3D8-induced apoptosis of NB4 cells. However, the apoptotic process is independent of TNF-family death receptor signalling. Interestingly, the general serine protease inhibitor 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF) decreases A3D8-induced apoptosis and when combined with general caspase inhibitor displays an additive effect resulting in complete prevention of apoptosis. These results suggest that both caspase-dependent and serine protease-dependent pathways contribute to A3D8-induced apoptosis. Finally, A3D8 induces apoptosis in all-trans-retinoic acid-resistant NB4-derived cells and in APL primary blasts, characterizing the A3D8 anti-CD44 mAb as a novel class of apoptosis-inducing agent in APL. 相似文献
38.
The ontogeny of type I and type II benzodiazepine binding sites was studied in mouse cerebellum by displacement of [3H]flunitrazepam binding by zolpidem, a ligand specific for the type I sites. Type I binding sites predominate throughout development and in the adult while type II sites account for 25% of total cerebellar benzodiazepine binding sites at birth and, during development, decrease to 10% or less in the adult. On a per cerebellum basis type II sites increase during the first postnatal week and then remain at a steady level while type I sites increase until adulthood. These results may indicate a specific localization of the type II sites (and of the corresponding alpha-protein subunits in the GABA/benzodiazepine receptor complex) in structures already present at birth and developing during a short early postnatal period. The affinity of zolpidem for its high affinity (type I) binding sites increases during cerebellar ontogeny, this increase possibly indicates an epigenetic (post-translational) 'maturation' process of the corresponding receptor molecule. Hill numbers indicate the existence of an additional binding site heterogeneity greater during development but still present in the adult; probably this is to be related to the simultaneous presence of different 'maturation' stages during development and with a certain variety of the final products. 相似文献
39.
S J Graafsma L J van Tits P van Heijst J Reyenga J F Rodrigues de Miranda T Thien 《Journal of cardiovascular pharmacology》1989,14(4):598-602
The effect of handgrip (HG) isometric exercise on plasma catecholamines, alpha 2-adrenoceptors on platelets and beta 2-adrenoceptors on lymphocytes was studied in normotensive subjects (NT) and essential hypertensive subjects (HT). Whereas systolic blood pressure (SBP) increases were similar in NT and HT subjects, diastolic blood pressure (DBP) and heart rate (HR) increased more in the former group. Baseline values and changes in plasma epinephrine (E) and norepinephrine (NE) did not differ between both groups. No differences were apparent in alpha 2-adrenoceptor density and affinity between NT and HT subjects before or after the test. HG isometric exercise induced a similar increase in beta 2-adrenoceptors on lymphocytes of 22 +/- 7 and 13 +/- 5% in NT and HT subjects, respectively. Affinity to the beta 2-adrenoceptors under baseline conditions was somewhat lower in HT (8.1 +/- 0.4 pM) than in NT subjects (6.5 +/- 0.5 pM), and this difference persisted during the test. Our results indicate that there are no differences in alpha 2- and beta 2-adrenoceptor densities either at baseline conditions or after HG isometric exercise between NT and HT subjects. Small differences noted in affinity to the beta 2-adrenoceptors require further investigation. 相似文献
40.
M. D. Taylor M. L. de Ceballos S. Rose P. N. Chong P. Jenner C. D. Marsden 《Journal of neural transmission (Vienna, Austria : 1996)》1991,3(2):99-108
Summary Aged common marmosets were treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; 0.5–2.0 mg/kg/week i.p.) for 16 or 24 weeks, observed for a total of 30 weeks and then killed for measurement of biochemical pramaters in basal ganglia. The MPTP treatment induced a marked depletion in dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic acid levels in the caudate nucleus and putamen. In contrast, the concentrations of five neuropeptides: [Met5]-enkephalin, [Leu5]-enkephalin, cholecystokinin, substance P and neurotensin as measured by a combined HPLC/RIA method, remained unaltered in all basal ganglia regions examined. Enkephalin precursor levels, as reflected by cryptic [Met5]-enkephalin content, were increased in the putamen, but not in the caudate nucleus, as a consequence of MPTP administration. Cryptic [Leu5]-enkephalin content remained unchanged in the striatum of MPTP treated marmosets. Overall, these results suggest an increase in striatal [Met5]-enkephalin release following chronic MPTP treatment of aged marmosets. However, the chronic treatment of aged marmosets with MPTP does not reproduce the neuropeptide alterations characteristic of Parkinson's disease. 相似文献